2023 has brought major changes in the clinical research technology industry. As research sites face a backlog of clinical trials, they’re becoming more selective with which studies they take on.
A holistic approach to problem solving is necessary to address the complex issues facing healthcare providers today. Despite the demands of the current environment, quality must remain the top ...
The request for information comes as the Trump administration has largely taken a deregulatory stance on AI, in a bid to ...
Significant reduction in cognitive load and after-hours charting ...
Fiza Shaukat is a native of Pakistan living in the United States. As a biomedical engineer, she was eager to improve her country’s medical devices and digital health strategies. She approached us in ...
In the latest webinar of HealthLeaders' The Winning Edge series, a three-member panel will explore clinical care technology beyond artificial intelligence. In recent years, artificial intelligence has ...
CAMBRIDGE, Mass., Dec. 24, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company advancing biotherapeutic ...
At Inventus, we believe in creating solutions that simplify the complexities of device provisioning in the world of clinical trials. Founded in 2020, we are the world’s only Original Equipment ...
PHOENIX, Sept. 19, 2023 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on a regenerative ...
Conversational AI technology is spurring a wave of innovation between tech companies and healthcare organizations. This article appears in the July/August 2021 edition of HealthLeaders magazine. Over ...
AIIMS Delhi pioneers India's first clinical trial of the Supernova brain stent, showing promising results for severe stroke treatment.
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results